Olimab 60mg Denosumab Injection

Olimab 60mg Denosumab Injection is a prescription medication used to treat osteoporosis and other conditions associated with bone loss in individuals at high risk of fractures. It contains Denosumab, a monoclonal antibody that works by blocking RANKL (Receptor Activator of Nuclear Factor Kappa-B Ligand), a protein responsible for bone breakdown. By reducing bone resorption, Olimab 60mg Denosumab Injection helps increase bone mineral density, strengthen bones, and lower the risk of fractures. Administered as a subcutaneous injection under the supervision of a healthcare professional, it is commonly prescribed as part of a comprehensive bone health management plan. Regular monitoring of calcium levels and bone density is important during treatment to ensure safety and effectiveness. Patients should use Olimab 60mg Injection only as directed by their healthcare provider.